SC

Subhash Chand

Director Director DIN 00869704
DIN 00869704 First appointment Jul 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2004
Shareholding value Locked Premium profile

About Subhash Chand

Data last updated:

Subhash Chand has 22 years in corporate governance. Formerly with 1 company, such as Ultra Bioremedies Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00869704
Primary Designation Director
First Appointment 30 Jul 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Ultra Bioremedies Private Limited U33112DL1998PTC093944
Director30 Jul 20041998Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ultra Bioremedies Private Limited
Premium access

Shareholding and investment profile for Subhash Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chand

Subhash Chand has 22 years in corporate governance. Formerly with 1 company, such as Ultra Bioremedies Private Limited. Engaged in General Business. Contributes to corporate operations.

Subhash Chand is associated with 0 companies as a director.

Subhash Chand has expertise in General Business.

Subhash Chand has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available